Cyclazodone

This classification denotes a cns stimulant with the molecular formula C12H12N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O8U55ZRL9K, chemically known as 4(5h)-oxazolone, 2-(cyclopropylamino)-5-phenyl- (9ci) but generally known as cyclazodone, which bears US NIH Compound Identifier 26701. European Medicines Agency schedules Cyclazodone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06844MIG. The term CYCLAZODONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). CYCLAZODONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cyclazodone under HS 29349990 and SITC 51579. As of Q4 2014, CYCLAZODONE remains the US FDA Preferred Term for this commodity. Cyclazodone bears US NLM identifiers UMLS ID C2825428 and NCI Concept Code C81049. SMILES: C1CC1NC2=NC(=O)C(O2)C3=CC=CC=C3.